Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01312519 · ClinicalTrials.gov registry record · NA
Powered Bone Marrow Aspiration and Core Biopsy System Compared to Manual Devices
A NA study, sponsored by Vidacare Corporation.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01312519: Completed NA study, sponsored by Vidacare Corporation.
NCT01312519 is a NA study that has completed, run by Vidacare Corporation. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01312519, a NA study, has completed, sponsored by Vidacare Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a randomized study evaluating use of a powered bone marrow biopsy and aspiration system (OnControl by Vidacare) compared to traditional manual devices. The hypothesis is that the powered system will reduce the level of patient pain during the aspiration and core biopsy procedures and the amount of time needed to perform the procedures.
Primary Outcome
Subjects were asked to rate the level of pain they experienced during the procedure for needle insertion, following penetration of the cortex. A 0 to 10 pain scale was used where 0=no pain and 10= worst possible pain.
Interventions
- DEVICE OnControl Bone Marrow Biopsy and Aspiration System
- DEVICE Manual bone marrow sampling device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT01312519 record still lists
NCT01312519 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which OnControl Bone Marrow Biopsy and Aspiration System is the first listed.
NCT01312519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01312519 about?
NCT01312519 is a clinical study titled "Powered Bone Marrow Aspiration and Core Biopsy System Compared to Manual Devices". This is a randomized study evaluating use of a powered bone marrow biopsy and aspiration system (OnControl by Vidacare) compared to traditional manual devices. The hypothesis is that the powered system will reduce the level of patient pain during the aspiration and core biopsy procedures and the amo...
What is the current status of trial NCT01312519?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-01. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01312519?
The interventions under investigation include: OnControl Bone Marrow Biopsy and Aspiration System (DEVICE), Manual bone marrow sampling device (DEVICE).
Who is sponsoring clinical trial NCT01312519?
This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01312519's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia